Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Retained Earnings (2023 - 2025)

Historic Retained Earnings for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to -$288.3 million.

  • Metagenomi's Retained Earnings fell 4445.7% to -$288.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$288.3 million, marking a year-over-year decrease of 4445.7%. This contributed to the annual value of -$223.0 million for FY2024, which is 5385.39% down from last year.
  • As of Q3 2025, Metagenomi's Retained Earnings stood at -$288.3 million, which was down 4445.7% from -$267.9 million recorded in Q2 2025.
  • Over the past 5 years, Metagenomi's Retained Earnings peaked at -$144.9 million during Q4 2023, and registered a low of -$288.3 million during Q3 2025.
  • For the 3-year period, Metagenomi's Retained Earnings averaged around -$215.4 million, with its median value being -$211.3 million (2024).
  • Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 5385.39% in 2024, then crashed by 4445.7% in 2025.
  • Metagenomi's Retained Earnings (Quarter) stood at -$144.9 million in 2023, then tumbled by 53.85% to -$223.0 million in 2024, then decreased by 29.3% to -$288.3 million in 2025.
  • Its Retained Earnings stands at -$288.3 million for Q3 2025, versus -$267.9 million for Q2 2025 and -$248.0 million for Q1 2025.